Università Vita-Salute San Raffaele
🇮🇹Italy
Clinical Trials
78
Active:3
Completed:32
Trial Phases
4 Phases
Phase 1:1
Phase 3:8
Phase 4:11
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (55 trials with phase data)• Click on a phase to view related trials
Not Applicable
35 (63.6%)Phase 4
11 (20.0%)Phase 3
8 (14.5%)Phase 1
1 (1.8%)Photon Counting Computed Tomography in Heart Failure Patients
Not yet recruiting
- Conditions
- Heart Failure
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 150
- Registration Number
- NCT06964672
Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance
Not Applicable
Recruiting
- Conditions
- Low-Risk Prostate Cancer
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 74
- Registration Number
- NCT06866041
- Locations
- 🇮🇹
IRCCS Ospedale San Raffaele, Milan, Italy
Correlation and Rapid Analysis of Neurological Injury Using Markers
Not yet recruiting
- Conditions
- Traumatic Brain Injury (TBI) Patients
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 200
- Registration Number
- NCT06834659
- Locations
- 🇮🇹
IRCCS San Raffaele, Milan, Italy
Landiolol in Mitral Valve Surgery
Phase 4
Recruiting
- Conditions
- Cardiac FailureLow Cardiac Output Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 1500
- Registration Number
- NCT06793670
- Locations
- 🇮🇹
Ospedale San Raffaele, Milano, Italy
Multimodal Prehabilitation in Cancer Surgery
Not Applicable
Recruiting
- Conditions
- Cancer Surgery
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Università Vita-Salute San Raffaele
- Target Recruit Count
- 400
- Registration Number
- NCT06788834
- Locations
- 🇮🇹
Policlinico Universitario AOU Renato Dulbecco di Catanzaro, Catanzaro, Italy
🇮🇹AOU Careggi, Firenze, Italy
🇮🇹Ospedale Galliera di Genova, Genova, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
Novel BTK Degrader BGB-16673 Achieves 84.8% Response Rate in Heavily Pretreated CLL/SLL Patients
BGB-16673, a novel BTK protein degrader, demonstrated an 84.8% overall response rate in 66 heavily pretreated patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma in the phase 1/2 CaDAnCe-101 trial.